Ceva Santé Animale signed several agreements with the Vietnam Department of Animal Health to accelerate the implementation of preventive health strategies, including the research and development of new vaccines for the country's livestock sector.
Aided by strong growth in both income and population, Vietnam’s livestock sector has grown rapidly over the last decade, Ceva said.
Ceva has had operations in Vietnam for more than 12 years. By sharing its expertise in preventive animal health strategies through disease monitoring and effective vaccination control, the company is now a leading player in Vietnam, with strong positions in both the swine and poultry segments.
The agreements signed Jan. 16 illustrate Ceva’s commitment to support the Vietnam Ministry of Agriculture & Rural Development in its disease control initiatives during a period of unprecedented challenge following the outbreak of African swine fever (ASF) throughout Asia and some parts of Europe.
These initiatives include:
- A technology transfer collaboration aimed at developing more effective local foot and mouth disease vaccines specifically adapted to the local epidemiology.
- A scientific collaboration with Vietnam for ongoing vaccine research and development programs targeting ASF control.
“These new projects illustrate our commitment to bring preventative health strategies to Vietnamese livestock farmers by ensuring that the knowledge and expertise we have gained at a global level is practically adapted to meet local needs,” Ceva chairman and chief executive officer Marc Prikazsky said.
Ceva Santé Animale is a France-based multinational veterinary pharmaceutical company created in 1999. It specializes in the research, development, production and marketing of pharmaceutical products and vaccines for livestock (ruminants, swine, poultry) and companion animals. Ceva is present in 110 countries and employs more than 6,000 people worldwide.